New Zealand markets closed
  • NZX 50

    13,100.69
    -25.29 (-0.19%)
     
  • NZD/USD

    0.7167
    +0.0009 (+0.12%)
     
  • NZD/EUR

    0.6161
    +0.0011 (+0.17%)
     
  • ALL ORDS

    7,729.00
    +0.50 (+0.01%)
     
  • ASX 200

    7,417.70
    +2.30 (+0.03%)
     
  • OIL

    82.21
    -0.29 (-0.35%)
     
  • GOLD

    1,787.70
    +5.80 (+0.33%)
     
  • NASDAQ

    15,489.59
    +100.88 (+0.66%)
     
  • FTSE

    7,190.30
    -32.80 (-0.45%)
     
  • Dow Jones

    35,603.08
    -6.26 (-0.02%)
     
  • DAX

    15,472.56
    -50.36 (-0.32%)
     
  • Hang Seng

    26,122.10
    +104.57 (+0.40%)
     
  • NIKKEI 225

    28,921.50
    +212.92 (+0.74%)
     
  • NZD/JPY

    81.7220
    +0.1830 (+0.22%)
     

Promisia Healthcare (NZSE:PHL) Is Looking To Continue Growing Its Returns On Capital

·3-min read

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an eye out for. Amongst other things, we'll want to see two things; firstly, a growing return on capital employed (ROCE) and secondly, an expansion in the company's amount of capital employed. If you see this, it typically means it's a company with a great business model and plenty of profitable reinvestment opportunities. Speaking of which, we noticed some great changes in Promisia Healthcare's (NZSE:PHL) returns on capital, so let's have a look.

Understanding Return On Capital Employed (ROCE)

Just to clarify if you're unsure, ROCE is a metric for evaluating how much pre-tax income (in percentage terms) a company earns on the capital invested in its business. Analysts use this formula to calculate it for Promisia Healthcare:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

0.0038 = NZ$203k ÷ (NZ$59m - NZ$6.1m) (Based on the trailing twelve months to March 2021).

So, Promisia Healthcare has an ROCE of 0.4%. Ultimately, that's a low return and it under-performs the Personal Products industry average of 7.2%.

Check out our latest analysis for Promisia Healthcare

roce
roce

While the past is not representative of the future, it can be helpful to know how a company has performed historically, which is why we have this chart above. If you want to delve into the historical earnings, revenue and cash flow of Promisia Healthcare, check out these free graphs here.

So How Is Promisia Healthcare's ROCE Trending?

We're delighted to see that Promisia Healthcare is reaping rewards from its investments and is now generating some pre-tax profits. The company was generating losses five years ago, but now it's earning 0.4% which is a sight for sore eyes. And unsurprisingly, like most companies trying to break into the black, Promisia Healthcare is utilizing 3,618% more capital than it was five years ago. This can tell us that the company has plenty of reinvestment opportunities that are able to generate higher returns.

In another part of our analysis, we noticed that the company's ratio of current liabilities to total assets decreased to 10%, which broadly means the business is relying less on its suppliers or short-term creditors to fund its operations. So shareholders would be pleased that the growth in returns has mostly come from underlying business performance.

Our Take On Promisia Healthcare's ROCE

Overall, Promisia Healthcare gets a big tick from us thanks in most part to the fact that it is now profitable and is reinvesting in its business. Although the company may be facing some issues elsewhere since the stock has plunged 86% in the last five years. Regardless, we think the underlying fundamentals warrant this stock for further investigation.

If you'd like to know more about Promisia Healthcare, we've spotted 6 warning signs, and 2 of them are potentially serious.

If you want to search for solid companies with great earnings, check out this free list of companies with good balance sheets and impressive returns on equity.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting